These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16611781)

  • 1. Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement.
    van den Heuvel DM; ten Dam VH; de Craen AJ; Admiraal-Behloul F; van Es AC; Palm WM; Spilt A; Bollen EL; Blauw GJ; Launer L; Westendorp RG; van Buchem MA;
    AJNR Am J Neuroradiol; 2006 Apr; 27(4):875-8. PubMed ID: 16611781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.
    Gouw AA; van der Flier WM; van Straaten EC; Pantoni L; Bastos-Leite AJ; Inzitari D; Erkinjuntti T; Wahlund LO; Ryberg C; Schmidt R; Fazekas F; Scheltens P; Barkhof F;
    Cerebrovasc Dis; 2008; 25(3):247-53. PubMed ID: 18216467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
    van Straaten EC; Fazekas F; Rostrup E; Scheltens P; Schmidt R; Pantoni L; Inzitari D; Waldemar G; Erkinjuntti T; Mäntylä R; Wahlund LO; Barkhof F;
    Stroke; 2006 Mar; 37(3):836-40. PubMed ID: 16439704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
    Gouw AA; Van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Fazekas F; Scheltens P;
    J Neurol; 2006 Sep; 253(9):1189-96. PubMed ID: 16998647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
    Gao FQ; Swartz RH; Scheltens P; Leibovitch FS; Kiss A; Honjo K; Black SE
    J Alzheimers Dis; 2011; 26 Suppl 3():379-88. PubMed ID: 21971477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements.
    Kapeller P; Barber R; Vermeulen RJ; Adèr H; Scheltens P; Freidl W; Almkvist O; Moretti M; del Ser T; Vaghfeldt P; Enzinger C; Barkhof F; Inzitari D; Erkinjunti T; Schmidt R; Fazekas F;
    Stroke; 2003 Feb; 34(2):441-5. PubMed ID: 12574557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.
    Bocti C; Swartz RH; Gao FQ; Sahlas DJ; Behl P; Black SE
    Stroke; 2005 Oct; 36(10):2126-31. PubMed ID: 16179569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullseye's representation of cerebral white matter hyperintensities.
    Sudre CH; Gomez Anson B; Davagnanam I; Schmitt A; Mendelson AF; Prados F; Smith L; Atkinson D; Hughes AD; Chaturvedi N; Cardoso MJ; Barkhof F; Jaeger HR; Ourselin S
    J Neuroradiol; 2018 Mar; 45(2):114-122. PubMed ID: 29132940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics.
    Prins ND; van Straaten EC; van Dijk EJ; Simoni M; van Schijndel RA; Vrooman HA; Koudstaal PJ; Scheltens P; Breteler MM; Barkhof F
    Neurology; 2004 May; 62(9):1533-9. PubMed ID: 15136677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a practical visual MRI rating scale of brain white matter hyperintensities for clinicians based on largest lesion size regardless of location.
    King KS; Peshock RM; Warren MW; Alhilali L; Hulsey K; McColl R; Weiner MF; Ayers C; Whittemore A
    AJNR Am J Neuroradiol; 2013 Apr; 34(4):797-801. PubMed ID: 23079403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the computational assessment of white matter hyperintensity progression: difficulties in method selection and bias field correction performance on images with significant white matter pathology.
    Valdés Hernández Mdel C; González-Castro V; Ghandour DT; Wang X; Doubal F; Muñoz Maniega S; Armitage PA; Wardlaw JM
    Neuroradiology; 2016 May; 58(5):475-85. PubMed ID: 26833053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function.
    Tiehuis AM; Vincken KL; Mali WP; Kappelle LJ; Anbeek P; Algra A; Biessels GJ
    Cerebrovasc Dis; 2008; 25(1-2):59-66. PubMed ID: 18033959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection.
    Robinson-Papp J; Navis A; Dhamoon MS; Clark US; Gutierrez-Contreras J; Morgello S
    J Neuroimaging; 2018 Mar; 28(2):217-224. PubMed ID: 28833868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrater reliability of modified visual mrı rating scale assessing atrophy and white matter changes.
    Yilmaz MK; Yalciner ZB; Tepe SM
    Ideggyogy Sz; 2023 Jan; 76(1-2):19-24. PubMed ID: 36892299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and comparison of two automated methods for quantifying brain white matter hyperintensities of presumed vascular origin.
    Waymont JMJ; Petsa C; McNeil CJ; Murray AD; Waiter GD
    J Int Med Res; 2020 Feb; 48(2):300060519880053. PubMed ID: 31612759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities.
    Noh Y; Lee Y; Seo SW; Jeong JH; Choi SH; Back JH; Woo SY; Kim GH; Shin JS; Kim CH; Cho H; Park JS; Lee JM; Hong CH; Kim SY; Lee JH; Kim SY; Park KH; Han SH; Cheong HK; Na DL
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):636-42. PubMed ID: 23867045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities.
    Griffanti L; Zamboni G; Khan A; Li L; Bonifacio G; Sundaresan V; Schulz UG; Kuker W; Battaglini M; Rothwell PM; Jenkinson M
    Neuroimage; 2016 Nov; 141():191-205. PubMed ID: 27402600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Rating Scales of White Matter Hyperintensities and Atrophy: Comparison of Computed Tomography and Magnetic Resonance Imaging.
    Ferguson KJ; Cvoro V; MacLullich AMJ; Shenkin SD; Sandercock PAG; Sakka E; Wardlaw JM
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1815-1821. PubMed ID: 29576397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.